semaglutide side effects blurry vision linked to higher risk of problems, FDA data analysis shows Common And Rare Side Effects

Who cant take Ozempic or tirzepatide

Clinical data from the STEP 1 trial shows average weight loss of approximately 5.9 percent of baseline body weight at 12 weeks

The initial weight loss often includes water weight as tirzepatide reduces food intake and begins altering metabolic function

If the question is "what does the science suggest is coming," retatrutide's phase 2 weight-loss and liver-fat numbers are genuinely notable but "promising in phase 2" and "proven and approved" are very different standards, and the gap between them is exactly what phase 3 exists to test

Same dose

For patients on semaglutide monotherapy for obesity without diabetes, the hypoglycemia risk is lower but not zero, especially when drinking on an empty stomach